Skip to content

Author

K. Khunti

We have 10 of 2,027 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Bariatric surgery and risk of dementia and Parkinson's disease in patients with obesity.

OBJECTIVE We aimed to evaluate the association between bariatric surgery (BS) and the incidence of dementia and Parkinson's disease. To assess consistency with established benefits of BS, we examined its association with cardiovascular disease, obesity-associated cancers, and all-cause mortality. METHODS We conducted...

S. Shiekh, D. Papamargaritis, J. Goldney et al. · 0 citations
Open access Jul 2026

Learning from scale-up: a qualitative study of scaling-up interventions for people with multiple long-term conditions in primary care

Abstract Background Scaling innovations for people living with multiple long-term conditions (MLTCs or multimorbidity) remains challenging, particularly in primary care, where organisational capacity, infrastructure, and local contexts vary widely. There is limited empirical understanding of the implementation work nee...

Sarah Chew, Natalie Armstrong, G. Maniatopoulos et al. · 0 citations
Open access Oct 2026

Identifying fibrotic interstitial lung disease risk in COPD, asthma and heart failure

Fibrotic interstitial lung disease (fILD) is often diagnosed late and can be difficult to recognise in people with common respiratory or cardiac long-term conditions. We examined whether baseline routine blood-test profiles and leucocyte telomere length (LTL) identified groups at higher risk of subsequent hospital-...

G. Lough, L. Wain, A. Meffen et al. · 0 citations
Review Oct 2026

Diabetes and the role of primary care: a global perspective.

The global prevalence of diabetes is rising rapidly, with the steepest increases and greatest unmet need occurring in low-income and middle-income countries. Despite strong evidence that early detection and continuous management reduce morbidity and mortality, many health systems face persistent gaps in diagnosis, trea...

Partha Kar, H. Sathanapally, P. Aschner et al. · 0 citations
Open access Jan 2026

Uncontrolled Hypertension in Cardio‐Renal‐Metabolic Diseases: Real‐World Insights on Patient Profiles and Management Patterns From iCaReMe Global Registry

Background Hypertension (HTN) is a leading risk factor for cardiovascular (CV) and renal morbidity and mortality, yet blood pressure (BP) control remains suboptimal worldwide. Understanding management patterns, especially among patients with coexisting Type 2 diabetes mellitus (T2DM), chronic kidney diseases (CKDs), or...

K. Khunti, M. Arıcı, Carol A. Pollock et al. · 0 citations
Open access Sep 2026

Glycemic Markers and Cardiometabolic Multiple Long-Term Conditions: Comparative Roles of Glycated Hemoglobin and Fasting Plasma Glucose in the English Longitudinal Study of Ageing

Objective To examine and contrast the associations of glycated hemoglobin (HbA1c) and fasting plasma glucose (FPG) with the risk of cardiometabolic multiple long-term conditions (cMLTC) and evaluate their incremental predictive utility. Patients and Methods The study analyzed 2233 adults (mean age 63; 1009 (45.2%) men)...

S. Seidu, S. Kunutsor, K. Khunti · 0 citations
Open access Sep 2026

Effectiveness of Adding GLP-1 Receptor Agonists to SGLT2 Inhibitor Therapy in Chronic Kidney Disease: A Population Based Study.

BACKGROUND Individually, sodium-glucose co-transporter-2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1RAs) have been shown to reduce major kidney and cardiovascular events in patients with chronic kidney disease (CKD). However, evidence supporting combined GLP-1RA and SGLT2i therapy in this p...

Hussain Salim, Shaheer Qureshi, G. Gulsin et al. · 0 citations
Open access Sep 2026

Increasing burden of multiple long-term conditions and mortality risk following COVID-19 diagnosis: a national cohort study of one million adults with cardiovascular disease in England.

MLTCs burden was a stronger determinant of mortality risk than CVD subtype alone, andFindings support moving beyond single-disease models towards integrated, MLTC-informed care, and pandemic preparedness.

Yogini V. Chudasama, S. Shabnam, K. Khunti et al. · 0 citations
Aug 2026

Association of Lipid Ratios With Cardiovascular Outcomes in Type 2 Diabetes: A Population Cohort Study

To identify low‐ and high‐risk intervals for major adverse cardiovascular events (MACE) and all‐cause mortality according to lipid ratios in adults with Type 2 diabetes mellitus (T2DM), stratified by sex.

E. Carretero-Anibarro, J. Quesada, Manuel A. Ruiz-Quintero et al. · 0 citations
Review Open access Jul 2026

Comparative effects of drugs for adults with overweight or obesity: systematic review and network meta-analysis

Moderate to high certainty evidence supports discontinuation of drugs for adults with overweight or obesity because of adverse events to be highest with orforglipron, naltrexone-bupropion, liraglutide, phentermine-topiramate, CagriSema, and oral semaglutide.

Kai-Lei Nong, Qingyang Shi, Xinran Xie et al. · 5 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.